Recently, the upsurge in hospital-acquired diseases has put global health at risk.
Biomedical implants being the primary source of contamination, the development of …

Advances in biomaterial synthesis and fabrication, stem cell biology, bioimaging,
microsurgery procedures, and microscale technologies have made minimally invasive …

Long‐term blood‐contacting devices (eg, central venous catheters, CVCs) still face the
highest incidence of blood stream infection and thrombosis in clinical application. To …

Purpose Infectious complications associated with central venous catheters (CVCs) are a
major source of morbidity and mortality among hemodialysis (HD) patients. This review aims …

Background Central venous catheters (CVC) continue to play a prominent role in
haemodialysis vascular access with 46% to 70% of patients commencing haemodialysis via …

Background The most appropriate lock solution for central venous access devices is still to
be defined. GAVeCeLT–the Italian group for venous access devices–has developed a …

Purpose To describe all post-insertion complications involving most used intravascular
access, and to determine whether the use of a new-generation transparent dressing (3M™ …

Antimicrobial lock solutions are effective in preventing catheter-associated bloodstream
infections and their effect is additive to standard prevention measures. Nonantibiotic …

This Review focuses on the changing epidemiology of infections among patients with end-
stage renal disease who are undergoing dialysis. In particular, bloodstream infections …

Background Patients undergoing haemodialysis (HD) through a central venous catheter
(CVC) are exposed to several risks, being a catheter‐related infection (CRI) and a CVC …